Cancer testis antigen burden: A novel predictive biomarker for immunotherapy in solid tumors

Labcorp and National Kidney Foundation promote patient registry to enhance clinical trial accessibility, diversity

BURLINGTON, N.C. & NEW YORK --(BUSINESS WIRE)--Nov. 4, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, and the National Kidney Foundation (NKF), the largest patient organization dedicated to the prevention and treatment of kidney disease, announced their collaboration to promote the NKF Patient Network, the first national registry for chronic kidney disease (CKD) patients in the U.S. The NKF Patient Network will offer greater data and insights to physicians, as well as improved clinical trial access for patients with kidney disease.

Labcorp to speak at Credit Suisse 30th annual healthcare conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 2, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of its executive management team will participate in a virtual fireside chat at the Credit Suisse 30th Annual Healthcare Conference on Tuesday, Nov. 9 at 1:00 p.m. ET.

Dr. Marcia Eisenberg, Labcorp Diagnostics Chief Scientific Officer, named to Fierce Healthcare’s 2021 Women of Influence

BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 1, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that Marcia Eisenberg , Ph.D., chief scientific officer of Labcorp Diagnostics , was recognized by Fierce Healthcare as one of its “2021 Women of Influence.” The award honors leaders who are defining the future of health care, have tangibly influenced the industry during the prior year and have a history of guiding others in their careers.

Labcorp announces 2021 third quarter results

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 28, 2021-- Labcorp (NYSE: LH), a leading life sciences company, today announced results for the third quarter ended September 30, 2021 , and raised full-year guidance.